Wide variations exist in the methods for evaluating potency following radical prostatectomy. We describe our technique of laparoscopic radical prostatectomy (LRP), present our methods for assessing the return of potency following LRP, and discuss the relevant literature. Sexual function was assessed pre-and postoperatively using the Expanded Prostate Cancer Index Composite questionnaire (EPIC). Sexual function subscale scores (SFSS) were reported as a percentage of preoperative baseline sexual function. The EPIC was also used for single-question assessment of successful intercourse. We also reviewed the literature on prospective health-related quality of life results following LRP and open radical retropubic prostatectomy. Only patients reporting preoperative intercourse were analyzed. Of these, 72 and 35% undergoing bilateral and unilateral nerve sparing (NS) reported postoperative intercourse at 12 months (P ¼ 0.01). Mean SFSS at 12 months was 61 and 57% of baseline after bilateral and unilateral NS, respectively (P ¼ 0.71). Following NS procedures, 74% of patients p58 years of age and 41% of patients 458 years of age reported successful intercourse at 12 months (P ¼ 0.015). Mean SFSS was 64 and 52% of baseline function (P ¼ 0.249) at 12 months for patients p58 and 458 years of age, respectively. In patients o58 years of age who underwent bilateral NS surgery, 82% reported intercourse at 12 months. In conclusion, return of sexual function following NS LRP in our experience is comparable to reports from centers of excellence in open prostatectomy. Standardizing data collection using validated quality of life instruments can provide both surgeon and patient with a realistic forecast of relative return to normal sexual function following prostatectomy.
Introduction
Inherent in determining the relative success of any treatment modality for localized prostate cancer is the assessment of three main outcome measures: cancer cure, preservation of urinary continence, and return of sexual function. Since the mid-1900s surgical treatment of prostate cancer has been considered the standard by which other therapies have been compared. High-volume radical retropubic prostatectomy (RRP) centers report excellent oncologic success as measured by 10-year biochemical-free survivals of 68-85%. 1, 2 Experienced surgeons have also refined surgical technique to allow for decreased blood loss and better visualization of the external striated sphincter and urethra, thus achieving continence rates of 490%. 3, 4 In contrast to the success observed with oncologic and continence end points, the preservation of postoperative sexual function has been far less consistent. Wide variations exist in reported potency rates following RRP. [4] [5] [6] [7] [8] Single surgeon case series describe potency rates from 76 to 86% in those men undergoing bilateral nerve sparing (NS) procedures. 4, 8 Others have reported potency rates after NS surgery as low as 21%, suggesting that case series are not representative of more global prostatectomy outcomes. 5, 9, 10 The reason for this wide variation is multifactorial. To begin with, erections, unlike continence, are dependent not only upon physiologic factors such as cavernous nerve function, but also upon various psychological, behavioral, and social factors. Therefore, inherent difficulties exist when critically evaluating a single variable (i.e. neurovascular bundle (NVB) preservation during prostatectomy) without the ability to control the remaining variables. Second, comparing studies from different institutions or national databases is confounded by differences in patient selection, experience/skill of the surgeons, surgical technique, and the often-subjective assessment of NVB preservation. Lastly, differing terminology is used to define successful postoperative sexual function (e.g. spontaneous erections vs successful intercourse) and differing methods of data collection (e.g. physician inquiry vs patient-reported validated survey) have been used in different studies. Taken together, these vagaries make it difficult for both surgeons and patients to realistically predict return of normal sexual function following prostatectomy.
Laparoscopic radical prostatectomy (LRP) has its basis in the anatomic RRP but enjoys the benefits of improved cosmesis, reduced blood loss, and shorter postoperative convalescence typical of laparoscopic surgery.
11 Although it will require at least 10-year follow-up to fully evaluate the oncologic success of LRP, the functional results of LRP from experienced centers appear comparable to most RRP series. 12, 13 Recently, there has been increased emphasis on patient-reported health-related quality of life (HRQOL) outcomes following treatment for prostate cancer. 5, 10, 12, [14] [15] [16] [17] Investigators have also developed validated instruments that were purposely designed to address the prostate-specific domains of urinary, bowel, and sexual function. 18 Pre-and postoperative assessment of HRQOL using these questionnaires allows each patient to serve as his own internal control, and is an ideal method of determining longterm functional outcome in each specified domain. In this manuscript, the authors will detail a method of pre-and postoperative assessment of sexual function that can be used to provide patients with a greater understanding of the likelihood, timing, and relative return to baseline sexual function following LRP.
Methods

Operative technique
We have previously described our technique of LRP, 19 which is accomplished using a modification of the Montsouris technique. 20 Our modifications have to do primarily with NVB preservation and are detailed here. Briefly, the patient is placed in the Trendelenburg position on the operating table. After CO 2 gas insufflation of the peritoneal cavity, four to five laparoscopic trocars are placed in an inverted U-shaped configuration below the umbilicus. Retrovesical dissection of the vas deferentia and seminal vesicles is first performed. As the cavernous nerves to the penis travel within the NVB and course within millimeters of the seminal vesicles, electrocautery is avoided during seminal vesicle dissection. The posterior dissection of the prostate gland is accomplished by dissecting between Denonvillier's fascia and the rectum. Access is then gained to the anterior prostate by dividing the urachus and entering the prevesical space of Retzius. The dorsal venous complex is ligated using intracorporeal suturing with 2-0 polyglactin suture.
The endopelvic fascia along the lateral aspect of the prostate is sharply incised, thus exposing the periprostatic fascial planes. The NVBs run along the posterolateral surface of the prostate and lie within an outer levator fascia and inner prostatic fascia (Figure 1) . In efforts to preserve the NVBs, bilateral NVB 'grooves' are created on the anterolateral aspect of the prostate. To avoid iatrogenic entry into the prostate gland, the levator fascia is superficially grasped and lifted off of the prostate, allowing a small incision to be made through this layer and exposing the underlying prostatic fascia. The prostatic fascia appears smooth, glistening and white, visibly different than the prostate parenchyma, which appears tan in color and more granular in texture. On occasion, large prostatic veins (i.e. venous branches of the deep dorsal venous complex) are encountered between the periprostatic fascial layers. In this instance, when possible, dissection should be carried out deep to these veins as they travel between the levator and prostatic fascia. Once the prostatic fascia is identified, the precise plane between the levator and prostatic fascia is then gently and bluntly developed using a fine-tipped right-angled clamp along the anterolateral surface of the prostate starting at the base and working towards the apex with the levator fascia incised along the way. Electrocautery is minimized during this dissection so as to avoid thermal injury to the cavernous nerves. 21 Dissection also continues Use of a validated quality of life questionnaire A Wagner et al deeper in a posterolateral direction and the NVBs are meticulously released bilaterally from the prostate resulting in two visible NVB bundle 'grooves'. This initial step serves to establish the proper plane for future antegrade dissection (i.e. from prostatic base to apex) and preservation of the NVBs. The prostate base is transected from the bladder using ultrasonic shears until the previously dissected seminal vesicles and vas deferentia are identified along the midline. Ligation of the prostatic pedicles at the 5 and 7 O'clock positions is accomplished using hemoclips. Using the previously established NVB 'grooves' as a guide, the remaining attachments between the NVB and prostate are released in an antegrade direction towards the prostatic apex. Dissecting close to the prostatic fascia during NVB dissection optimizes quantitative cavernous nerve preservation. Small hemoclips are used to secure traversing vessels between the NVB and prostate and electrocautery is avoided.
The prostatic apex is divided from the urethra after transection of the dorsal venous complex. The apical attachments between the prostate and NVBs are gently released thus completing the bilateral NVB dissection. A watertight vesicourethral anastomosis is created using interrupted polyglactin sutures and an 18-French foley catheter is placed before completion of the anastomosis. A closedsuction pelvic drain is left at the end of the operation and the prostate specimen is delivered through the umbilical incision prior to trocar-site closure.
Assessment of sexual function
Sexual function was assessed using the Expanded Prostate Cancer Index Composite (EPIC) questionnaire, a validated quality of life instrument developed specifically for the assessment of posttreatment quality of life in men with prostate cancer. The EPIC was developed at the University of Michigan and based on the previous UCLA-Prostate Cancer Index (UCLA-PCI). 18 The EPIC can be divided into domains for domain-specific analysis (urinary, bowel, sexual, hormonal), and into domain-specific subscales, such as the sexual function and sexual bother subscales. For this analysis, we focused on the sexual function subscale, as it provides the best EPIC-derived assessment of erectile performance.
Questionnaires were administered to patients privately and collected by research staff preoperatively and at 3, 6, and 12 months following LRP according to a protocol approved by our Institutional Review Board. Only patients with preoperative EPIC data and at least one later time point (3 months or beyond) were included, resulting in a final study cohort of 220 patients. Baseline EPIC sexual domain and subscale scores were normalized on a per patient basis to 100%. Sexual function subscale scores (SFSS) at 3, 6, and 12 months following LRP were calculated and reported as a percentage of baseline function for each individual patient. By collecting baseline data, each patient served as his own control, allowing our results to reflect each patient's individual return of sexual function compared to his unique baseline HRQOL scores. Those patients who did not fully complete the SFSS portion of the EPIC were excluded from that analysis.
Traditional single-question method for assessing postoperative sexual function was also determined using responses to EPIC item #63 ('During the last 4 weeks, how often did you have sexual intercourse?'), coding any response other than 'not at all' as a categorical affirmative for potency. Patients were considered potent when reporting intercourse with or without the assistance of phosphodiesterase-5 inhibitors (PDE-5I). Patients using other therapies such as the vacuum erection device, intraurethral prostaglandin, penile injection therapy, or penile prosthesis were not included as potent.
Statistical analysis EPIC scores were calculated using SAS software (SAS Institute, Cary, NC, USA) and a scoring macro available from the University of Michigan (http:// roadrunner.cancer.med.umich.edu/epic/epicmain. html). To compare mean values at a single time point for two different patient cohorts (i.e. stratified by age or NVB preservation status), the Student's T-test was used with statistical significance defined as a P-value o0.05.
Results
A total of 220 patients who have undergone LRP at our institution have at least 3-month follow-up data available for analysis. In all, 164/220 (75%) reported preoperative intercourse as measured by their answer to question 63 of EPIC and these patients are the focus of this analysis. The mean age of this study cohort was 58 years (range 41-75). A total of 10 (6%), 45 (27%), and 109 (66%) of these men underwent non-, unilateral, and bilateral NS, respectively. For this cohort, 144, 114, and 60 patients had 3, 6, and 12 month EPIC data available for analysis.
Effect of NS status on return of postoperative sexual function
We evaluated the impact of NS status on return of sexual function. Figure 1a displays the single question assessment of postoperative potency based on the degree of NS (unilateral vs bilateral) during
Use of a validated quality of life questionnaire A Wagner et al the first postoperative year. In the unilateral NS group, improvement in reported potency was noted between 3 and 6 months with little change at 12 months. Conversely, in the bilateral NS group, postoperative potency continued to improve during the postoperative study period with 72% of these patients reporting successful intercourse at 12 months. This is in contrast to only 35% of unilateral NS patients reporting successful intercourse at 12 months (P ¼ 0.01). Mean sexual function SFSS as a percentage of baseline preoperative function, and stratified based on NS status is shown in Figure 1b . At 12 months, mean SFSS after bilateral NS was 61% of baseline and after unilateral NS was 57% of baseline (P ¼ 0.710).
Effect of patient age on return of postoperative sexual function In preoperatively potent patients undergoing NS LRP (unilateral or bilateral), single question assessment of intercourse was stratified by patient age (Figure 2a) . The mean age of our patient population, 58 years, provided a convenient fulcrum for agerelated analysis of potency and as expected, there was a significant difference in potency at 6 and 12 months depending on age. At 6 months, 57% of patients p58 years of age and 29% of patients 458 years of age reported intercourse (P ¼ 0.005). At 12 months these results increased to 74 vs 41%, respectively (P ¼ 0.015). When we looked specifically at patients after bilateral NS surgery, 82% (n ¼ 22) and 57% (n ¼ 14) of patients p58 and 458 years of age, respectively, reported intercourse at 12 months (P ¼ 0.107). Figure 2b examines age as a function of postoperative SFSS in patients following a NS procedure. Mean SFSS were 64 and 41% of baseline function at 6 months (P ¼ 0.009), and 64 and 52% of baseline function at 12 months (P ¼ 0.249) for patients p58 and 458 years of age, respectively.
Discussion
With regards to erectile function following prostatectomy, there is a large disparity in reported potency and little consistency in the methods used to evaluate potency pre-and post-treatment. Individual probabilities for recovery of sexual function depend in part on the patient's preoperative sexual function and age. 3, 9 Other variables that have the potential to affect potency following prostatectomy include surgical approach (retropubic, perineal, laparoscopic, or robotic assisted), degree of cavernous nerve preservation, surgeon skill and experience, and hospital prostatectomy volume. 22, 23 Without a standardized method of evaluating sexual function, it is difficult or even impossible to compare results from different investigators. Moreover, surgeon assessments of quality of life are often at odds with data collected directly from patients. 24 Analysis of data obtained from patients using comprehensive validated HRQOL surveys may help to clarify postoperative expectations with regards to both the likelihood and relative quality of sexual function following NS prostatectomy.
Excellent potency outcomes following RRP have been reported from single-surgeon series. Walsh et al. 4 prospectively evaluated 64 potent men following RRP. Potency was determined using patient questionnaires with success defined by an affirmative response to the question 'over the last 4 weeks did you have vaginal or anal intercourse?'. After preserving the NVBs in 89% of patients, 86% regained potency at 18 months. In Catalona's series of over 3000 patients, 76% of preoperatively potent men with bilateral NS procedures were potent at 18 months. Return of potency was associated with age as 85 and 71% of men in their 50s and 60s regained erections, respectively. 8 Potency was not defined in this paper and much of the data were surgeon collected. Nevertheless, these single-surgeon series show that most patients can regain erections following NS surgery performed by experienced, high-volume surgeons, although information regarding the quality of erectile function was not provided by these studies. Despite their surgical expertise, the patient selection biases and high surgical volume inherent to these referral-based practices are not typical of most urology practices. Multisurgeon, patientreported HRQOL analysis from a single institution has revealed a significantly lower potency rate following RRP. Talcott et al. 25 reported only 9% of preoperatively potent patients had erections sufficient for intercourse 12 months after RRP at a tertiary academic center despite NS surgery in the majority of patients.
Other investigators have used pooled patient outcomes from national databases to determine the sexual function of patients treated in the community. Stanford et al. used the Surveillance, Epidemiology and End Results (SEER) database to evaluate 1291 men following RRP. Of patients undergoing bilateral NS procedures, 44% were potent at 18 months. Age was also assessed with younger patients reporting better overall function (39% potent for o60 years of age; 15.3% potent for ages 65-74). 9 Although this study had an impressive number of unselected patients, it did not include an assessment of sexual function prior to prostatectomy.
LRP was refined primarily in European centers and early series were reported by groups with extensive laparoscopic and open surgical experience. [26] [27] [28] [29] [30] Large-volume centers have described continence and early oncologic results comparable to open surgery. 12, 13, 31, 32 Recovery of sexual funcUse of a validated quality of life questionnaire A Wagner et al tion following LRP has also been reported to be comparable to open series. 13, 27, 29, [33] [34] [35] [36] Unfortunately, these studies have used varying methods of evaluating pre-and postoperative potency and none utilize the global sexual domain scores included in EPIC. Nevertheless, the 72% potency rate following bilateral NS LRP in our study population compares favorably to patient-reported potency of 53-67% following bilateral NS LRP in other reported series. 13, 35, 36 Several groups have directly compared LRP to RRP and found a similar recovery of sexual function between the two techniques. 29% (30) 59% (19) 57% (14) 42% (67) 53% (54) 61% ( (31) 57% (60) 33% (78) 41% (22) 29% (42) 20% ( 64% (27) 40% (57) 64% (44) 52% (14) 35% (40) 41% ( Use of a validated quality of life questionnaire A Wagner et al control. To our surprise SFSS for unilateral and bilateral NS patients were similar (i.e. 57 vs 61% of baseline function, respectively, P ¼ 0.71) despite a significantly higher percentage of men in the bilateral cohort reporting successful intercourse. This similarity may have several explanations including simply a lack of sufficient sample size to detect a difference between the two groups. This finding may also result from a difference in baseline SFSS between the uni-and bilateral NS groups. Interestingly, we found the mean baseline raw SFSS to be 65 and 72 in the uni-and bilateral groups, respectively (P ¼ 0.017). This higher baseline SFSS in the bilateral cohort sets a higher bar for these patients to return to following surgery and could explain their lower than expected score when compared to the unilateral group. A further explanation might be the rather subjective and surgeondependent coding of non-vs unilateral vs bilateral cavernous nerve preservation at the time of surgery. Nevertheless, with experience our ability to accomplish successful NVB preservation has improved as 72% of our last 50 patients received bilateral NVB preservation compared to only 47% of our first 50 patients (unpublished data) ( Figure 3 ). Similar to previous studies, our study supports the finding that younger age favors recovery of sexual function following NS prostatectomy. 8, 15, 17 Using 58 years (the mean age of our patient cohort) as a cutoff, 74% of patients under 58 years and 41% of those over 58 years reported intercourse 1 year following NS surgery. Moreover, 82% of patients younger than 58 years who underwent bilateral NS surgery reported intercourse at 12 months. Mean SFSS at 6 and 12 months favored younger patients however the difference at 12 months did not reach statistical significance. This lack of significance may be explained by the lower baseline SFSS scores in the older compared to the younger cohort (i.e. mean baseline raw SFSS score 58 vs 68, respectively) with the older patients therefore having a lower set point for return to baseline sexual function as compared to the younger patients.
With regards to preoperative counseling, although most patients appreciate knowing their likelihood of intercourse and relative return to baseline function following surgery, others may want to know the odds of a complete return to 'normal' baseline sexual function. Using HRQOL outcomes, Hu et al. 17 used a cutoff of X75% of baseline sexual function and found that 20% of their patients achieve baseline potency following surgery, although NS status was not accounted for. Applying this same criteria to our study cohort, we found 13/27 (48%) of patients undergoing bilateral NS returned to X75% of baseline sexual function at 12 months following LRP.
Our study is limited by the relatively small patient numbers and intermediate follow-up of only 1 year. Others have found sexual function to increase up to 24 months following surgery. 15, 16 Therefore, we anticipate continued improvement in sexual function as follow-up extends beyond 1 year. Continued longitudinal follow-up with the EPIC questionnaire in our LRP patients is ongoing at our institution.
Conclusions
There is a disheartening lack of uniformity in measuring baseline and postoperative sexual function following radical prostatectomy. Many early studies relied on surgeon-collected data or nonvalidated questionnaires. More investigators are increasingly relying upon validated HRQOL instruments to assess functional outcomes in their patients. Mid-term analysis suggests that LRP is a reliable, safe, and oncologically sound procedure with functional results equivalent to RRP. We have used the EPIC questionnaire to prospectively assess the functional outcomes of LRP at our institution. By stratifying for age and NS procedure, we can provide potent patients with further specific information regarding their potential for sexual recovery. For example, patients who receive bilateral NS surgery are now counseled that 72% are likely to engage in successful intercourse at 12 months with or without the use of PDEI-5. Using results from the EPIC SFSS, these patients may also be told that they will on average regain approximately 60% of their preoperative sexual function during the same period. In addition, for younger patients (e.g. p58) who are potent preoperatively and receive bilateral NS surgery, 82% are likely to have successful intercourse at 12 months as compared to only 57% of patients older than 58 years. Using prospectively collected, validated HRQOL instruments such as EPIC, academic, and community urologists alike can monitor their own outcomes, thus providing their patients with accurate and realistic expectations for recovery of sexual function.
